Yuko Tanabe

8PUBLICATIONS
38CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsCancer diagnosisInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 13, 2026
Continuous glucose monitoring reveals bimodal glycemic patterns during and outside Capivasertib administration.

Yuya Suzuki, Takeshi Yamaguchi, Takayasu Uchida

|May 22, 2025
Prognosis of Invasive Lobular Carcinoma and Effectiveness of Eribulin in Clinical Practice: A Post Hoc Analysis of a 2-Year Post-Marketing Surveillance.

Yuko Tanabe, Kenichi Inoue, Masato Takahashi

|May 20, 2024
Long-term outcomes of neoadjuvant trastuzumab emtansine + pertuzumab (T-DM1 + P) and docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP) for HER2-positive primary breast cancer: results of the randomized phase 2 JBCRG20 study (Neo-peaks).

Toshimi Takano, Norikazu Masuda, Mitsuya Ito

|Jan 07, 2024
Third Report of the Japan Diabetes Society/Japanese Cancer Association Joint Committee on Diabetes and Cancer: Summary of the results of a questionnaire survey of oncologists and diabetologists-Secondary publication.

Atsushi Goto, Ken Ohashi, Mitsuhiko Noda

|Dec 11, 2023
Reliability and validity of the Japanese version of the Chemotherapy-induced Alopecia Distress Scale.

Yosuke Aoyama, Eri Hoshino, Akihiko Shimomura

|Nov 29, 2023
Growth Hormone Therapy for Small for Gestational Age Short Stature Develops Type 2 Diabetes.

Naohiro Nomura, Yuko Tanabe, Miki Minami

Pageof 2

Frequent Collaborators

1 joint publications

Shigehiro Koganemaru

1 joint publications

Mayu Yunokawa

1 joint publications

Kenji Tamura

1 joint publications

Naohiro Nomura